Latest Headlines

Follow companies to personalize your feed

Today

Regener8 Resources NlBusiness

Shareholders Approve Srebrenica North Acquisition

in 2 hours

Atlas ArteriaBusiness

ALX - Panel Receives Application

in an hour

Finder Energy Holdings LimitedBusiness

Share Purchase Plan Offer Open

in 39 minutes

Gpt GroupBusiness

March quarter 2026 operating update

20 minutes ago

Yeahka LimitedBusiness

Former Visa Asia Pacific Executive David Tay Joins YeahPay as Global Vice President

27 minutes ago

Stavely Minerals LtdBusiness

Follow-Up Drilling at Freddy's Find Gold and Silver Prospect

27 minutes ago

Southern Hemisphere Mining LimitedBusiness

Diamond Drilling Program Commenced To Expand Llahuin

38 minutes ago

Bwp TrustBusiness

Investor Presentation

40 minutes ago

Askari Metals LimitedBusiness

Trenching Results at PS Confirm Continuous Mineralisation

an hour ago

Freehill Mining Ltd.Business

Aggregate gross sales are up 23% month-on-month to a record

an hour ago

Decidr Ai Industries LtdBusiness

Successful Completion of $15m Placement

an hour ago

Scorpion Minerals LimitedBusiness

New Gold Exploration Target at Old Prospect

an hour ago

Brightstar Resources LimitedBusiness

RIU Sydney Conference Presentation

an hour ago

Odessa Minerals LimitedBusiness

Successful A$2.65m Placement

an hour ago

Tg Metals Ltd.Business

Van Uden Laterite Gold Targets Defined

an hour ago

Avalo Therapeutics, Inc.Business

Avalo Therapeutics Announces Pricing of $375 Million Public Offering

an hour ago

Native Mineral Resources Holdings Ltd.Business

NMR enters into $3.5M convertible note raising

an hour ago

Bph Global LimitedBusiness

Binding MoU to Progress Development of Makassar Coastal Site

an hour ago

Dorsavi Ltd.Business

DVL advances modular ultra-edge hardware platform

an hour ago

Bwp TrustBusiness

Trading Halt

an hour ago

Business

Feb 11 2022

3 min read

Press Release Feb 11 2022

Name: 6ix Investment Platform
Brand: 6ix

Bal Pharma Limited has informed the Exchange regarding a press release dated February 11, 2022, titled "Bal Pharma Ltd maintains its strong growth momentum , reports growth in PAT of 23% YOY for 9MFY22. ".

View Attachment